Ogunbode 1979.

Methods	3‐arm active‐controlled randomised trial
Participants	144 women were randomised in a hospital setting in Nigeria. The population comprised women of unspecified parity, a singleton pregnancy, at both high and low risk for PPH, who delivered by vaginal delivery. Exclusion criteria comprised women undergoing instrumental delivery, or those with previous PPH, multiple pregnancy, polyhydramnios or vaginal lacerations.
Interventions	200 mcg or 500 mcg of ergometrine administered IM versus 500 mcg plus 5 IU of ergometrine plus oxytocin administered IM
Outcomes	The study recorded the following outcomes: PPH at 500; manual removal of placenta; blood loss (mL).
Notes	Contact with study authors for additional information: yes. Additional data from authors: no
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Restricted random allocation.
Allocation concealment (selection bias)	Unclear risk	Used sealed sequentially‐numbered envelopes.
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Quote: "The identity of the various drugs was not known to the investigators until after completion of the trial".
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Assessor blinding was not reported.
Objective assessment of blood loss	High risk	Investigators appraised blood loss by collection in a dish pressed against the vulva for 3 minutes: the contents were carefully measured.
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	The study authors did not mention any incomplete outcome data.
Selective reporting (reporting bias)	Unclear risk	The protocol of the study was unavailable for verification.
Intention to treat analysis	Low risk	All those who were enrolled and randomly allocated to treatment were included in the analysis, in the groups to which they were randomised.
Funding source	High risk	The study was supported by funding from Sandoz.